#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune demyelinating disease Neuropathic arthropathy Fontan procedure Trigeminal neuralgia Anti-HLA antibody test positive Waldenstrom's macroglobulinaemia recurrent Burkitt's lymphoma Cystic fibrosis respiratory infection suppression Andersen-Tawil syndrome Congenital megacolon Factor VIII deficiency Primary amyloidosis Rhabdomyosarcoma Adenocarcinoma pancreas Myelodysplastic syndrome with excess blasts More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Life with Disease Progressive multifocal leukoencephalopathy – Treatment Propionic acidaemia – Treatment Lysosomal storage disorder – Treatment Ewing’s sarcoma recurrent – Treatment Haemophagocytic lymphohistiocytosis – Basic Information Breast angiosarcoma metastatic – Trials in Disease Osteosarcoma recurrent – Diagnostics Niemann-Pick disease – Trials in Disease Alagille syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emactuzumab Ubiquinol ZIRCONIUM (89ZR) GIRENTUXIMAB Clobetasol Propionate Fluasterone CICLOPIROX Nesolicaftor Valganciclovir Hydrochloride Ecoo4 Ribonucleic Acid K30 Choriogonadotropin Alfa Efepoetin Alfa Neob Mk-0616 MAGNESIUM CARBONATE HEAVY Encaleret Sulfate Brexpiprazole Fumarate Naxitamab Baloxavir Marboxil Nido-361 More therapies…

    Learn about Your Condition

    Acute myeloid leukaemia Cervical dysplasia Post-traumatic stress disorder Biliary neoplasm Biliary tract disorder Myofascial pain syndrome Biliary cancer metastatic Post procedural swelling Postoperative wound infection Primary hyperaldosteronism Oesophagectomy Bone marrow disorder Biliary tract operation Hypervolaemia Metastases to rectum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Muscular dystrophy

  • Long-Term Safety and Efficacy of Oral Ribitol in Participants with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I/R9)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ribitol
    Denmark Germany Italy The Netherlands Norway

  • Study on the Effectiveness of Deflazacort in Treating LMNA-related Congenital Muscular Dystrophy in Adults and Children

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscular dystrophy
    Investigated Drugs:
    • Deflazacort
    Italy

  • Study on the Safety of ATA-200 Gene Therapy for Patients with Limb-Girdle Muscular Dystrophy Type R5

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscular dystrophy
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 8 Expressing The Human Gamma-Sarcoglycan Gene
    • Abiraterone Acetate
    • Lidocaine Hydrochloride Monohydrate
    France Italy

  • Study on the Effects of Ribitol (BBP-418) in Patients with Limb Girdle Muscular Dystrophy Type 2I

    Not recruiting

    3 1
    Investigated Diseases:
    • Muscular dystrophy
    Investigated Drugs:
    • Ribitol
    Denmark Germany Italy The Netherlands Norway

  • Gene Therapy Study for Patients with Limb-Girdle Muscular Dystrophy Using GNT0006

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscular dystrophy
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 9 Expressing The Human Fukutin Related Protein And Target Sequence Of The Mir-208A
    • Abiraterone Acetate
    • Lidocaine Hydrochloride Monohydrate
    Denmark France

  • Study on the Effects of EDG-5506 in Adults with Becker Muscular Dystrophy, McArdle Disease, or Limb-Girdle Muscular Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    • Glycogen storage disease type V
    • Muscular dystrophy
    • Becker’s muscular dystrophy
    Investigated Drugs:
    • Edg-5506
    Denmark

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!